Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TC Biopharm
Recent news which mentions TC Biopharm
3 Patients Already Dosed In TC BioPharm's Phase 2b Trial Of A Cutting Edge T Cell Therapy For Hard-to-Treat Cancers
January 26, 2023
Tickers
TCBP
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
November 22, 2022
Tickers
TCBP
TCBPW
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
Tickers
ACET
BMY
IPSC
TAK
Tags
Market News
TC Biopharm
TAK
From
Benzinga
TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments
August 08, 2022
Tickers
BMY
TCBP
TECH
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough
June 02, 2022
Tickers
BLUE
TCBP
Tags
Partner Content
TCBP
Biotech
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.